Tag: EGFR
Broad Molecular Testing in Lung Cancer: The Struggle to Translate Recommendations...
By Kara Nyberg, PhD
Posted: June 24, 2020
Over the past decade, lung cancer has emerged as a shining example of how precision medicine can dramatically...
Stunning Progress Achieved in Lung Cancer Treatment Over the Last Decade
By Kara Nyberg, PhD
Posted: April 16, 2020
After decades of failed clinical trials and persistently dismal lung cancer survival outcomes, the 2010s breathed new life...
Histologic Transformation From NSCLC to SCLC: A Mechanism of Resistance to...
By Denis Moro-Sibilot, MD, MSc
Posted: April 16, 2020
EGFR tyrosine kinase inhibitors (TKIs) are the standard of care for mutated EGFR NSCLC. Today, one of...
Letter to the Editor: Patient-Driven Research
By Jill Feldman, EGFR Resisters Co-Founder
Posted: December 11, 2019
I was so glad to see the article by Dr. Amy Moore on PDX models in the...
Adjuvant EGFR-TKI for Resected NSCLC: Who, When, and Where?
By Si-Yang Liu, MD, and Yi-Long Wu, MD
Posted: November 12, 2019
In the twentieth century, adjuvant chemotherapy became the standard of care for resected NSCLC...
